Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Tuberous Sclerosis 2Focal Cortical Dysplasia 2

Interventions

pembrolizumab 259Cyclophosphamide 242Specimen Handling 199fludarabine 174Magnetic Resonance Spectroscopy 174Biopsy 148Nivolumab 119Carboplatin 98Radiotherapy 92Paclitaxel 84venetoclax 82Cisplatin 81fludarabine phosphate 79Gemcitabine 79Injections 69Ipilimumab 63Dexamethasone 61atezolizumab 59Bevacizumab 59Cetuximab 57Azacitidine 56Radiation 55Fluorouracil 55durvalumab 54Radiosurgery 52Temozolomide 47Rituximab 44Oxaliplatin 44Irinotecan 43Docetaxel 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × radiprodil × 1 year × Clear all
NCT06965881 2025-11-21

Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults

GRIN Therapeutics, Inc.

Phase 1 Terminated
30 enrolled

Focal Cortical Dysplasia, Tuberous Sclerosis

NCT06975605 2025-11-18

Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

GRIN Therapeutics, Inc.

Phase 1 Completed
18 enrolled

Focal Cortical Dysplasia, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡